Josh Enomoto

Josh Enomoto

Brokering multi-million-dollar deals with some of the world’s biggest companies and providing in-depth marketing analyses, Josh Enomoto takes his firsthand knowledge of the corporate boardroom and delivers them across several media outlets. In addition to his work at InvestorPlace, Josh contributes content for Benzinga, TipRanks, EmergingGrowth and Blockster. He is also a guest expert at CGTN America.

While leaving no stone unturned regarding sector coverage, Josh has written extensively about cryptocurrencies. You can follow him on Blockster, a crypto-centric social media platform and on LinkedIn.

Recent Articles

5 Healthcare Stocks That Are Down, But Not Out!

Tough headwinds have impacted several healthcare stocks, presenting opportunities for risk-tolerant speculators.

American Eagle Stock Plummets to Earth Despite Earnings Beat

American Eagle stock delivered record sales in Q2, but weak guidance following a blistering rally in the markets killed the stock price.

Bank of America Stock Is in Trouble Under Trump

Bank of America stock previously enjoyed a “Trump boost,” but the President is now a liability due to ineffective policies that ignore a lot of key pieces of the economy.

IQiyi Stock Has Too Many Risks to Ignore

On the surface, IQ stock looks like an attractive opportunity. But when you look at iQiyi's fundamentals, it's clearly a flawed investment.

21 Beverage Stocks to Buy for the Contrarian-Minded

Changes in consumer habits have pressured beverage-makers, but the industry might be making a comeback, and these are some of the premiere beverage stocks to buy.

Micron Is a Victim of Geopolitics

Thanks to the escalating U.S.-China trade war, the once invulnerable MU stock suddenly finds itself on shaky ground. But Micron should recover over the longer term.

Foot Locker Slips Despite a Thorough Earnings Beat — Buy the Dip

From the top to the bottom line, FL stock delivers the goods against investor jitters towards the underlying sports-retail sector.

If You Liked Twitter Stock Before, You Should Like It More Now

Previously bullish investors left TWTR stock hanging after Twitter’s disappointing Q2 results, but the contrarian view is still alive.

Why Teva’s Outlook Is Mixed

TEVA stock is on a comeback rally after suffering two years of horrific losses, but its outlook is mixed.

Ulta Beauty Stock Still Has Much More Muscle to Flex

ULTA stock has suffered a choppy year in 2018, but the Ulta Beauty has multiple fundamental tailwinds offering longer-term upside.